How to buy Novacyt shares | 524p

Own Novacyt shares in just a few minutes. Share price changes are updated daily.

Fact checked

Novacyt S.A (NCYT) is a leading diagnostics & research business based in the UK. It opened the day at 516.52p after a previous close of 517.44p. During the day the price has varied from a low of 510p to a high of 594.84p. The latest price was 524p (25 minute delay). Novacyt is listed on the London Stock Exchange (LSE) and employs 110 staff. All prices are listed in pence sterling.

How to buy shares in Novacyt

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: NCYT in this case.
  5. Research Novacyt shares. The platform should provide the latest information available.
  6. Buy your Novacyt shares. It's that simple.
The whole process can take as little as 15 minutes.

How has Coronavirus impacted Novacyt's share price?

Since the stock market crash in March caused by coronavirus, Novacyt's share price has had significant positive movement.

Its last market close was 929p, which is 88.70% up on its pre-crash value of 105p and 2,996.46% up on the lowest point reached during the March crash when the shares fell as low as 30.002p.

If you had bought £1,000 worth of Novacyt shares at the start of February 2020, those shares would have been worth £3,350.52 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £19,154.68.

Novacyt share price

Use our graph to track the performance of NCYT stocks over time.

Novacyt shares at a glance

Information last updated 2020-09-29.
Open 516.52p
High 594.84p
Low 510p
Close 524p
Previous close 517.44p
Change 6.56p
Change % 1.268%
Volume 3,474,113
Information last updated 2020-10-20.
52-week range 6.5p - 980p
50-day moving average 499.4572p
200-day moving average 357.2447p
PE ratio 18.2819
Dividend yield N/A (0%)
Earnings per share (TTM) -26.2p
Promoted
eToro Free Stocks

Invest in Novacyt shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Your first 50 trades are free with Fineco, until 31/12/2020. T&Cs apply.
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Open an ISA, Trading Account or SIPP you will get £100 of free trades to buy or sell any investment (new customers only).
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
0.61%
N/A
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

Is it a good time to buy Novacyt stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Novacyt price performance over time

Historical closes compared with the last close of 524p

1 week (2020-11-17) -34.01%
1 month (2020-10-23) -56.11%
3 months (2020-08-24) 73.22%
6 months (2020-05-22) 63.75%
1 year (2019-11-22) 4,890.48%
2 years (2018-11-23) 1,397.14%
3 years (2017-11-24) 799.57%

Is Novacyt under- or over-valued?

Valuing Novacyt stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Novacyt's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Novacyt's P/E ratio

Novacyt's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Novacyt shares trade at around 18x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Novacyt financials

Gross profit TTM £8.3 million
Return on assets TTM 49.17%
Return on equity TTM 97.09%
Profit margin 45.54%
Book value 1.162p
Market capitalisation £679.9 million

TTM: trailing 12 months

Novacyt share dividends

We're not expecting Novacyt to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Novacyt share price volatility

Over the last 12 months, Novacyt's shares have ranged in value from as little as 6.5p up to 980p. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Novacyt's is -2.8374. This would suggest that Novacyt's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Novacyt has bucked the trend.

Novacyt overview

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, and commercialization of clinical diagnostic products for cancer and infectious diseases in Africa, Europe, the Asia Pacific, the United States, and the Middle East. The company operates through Corporate and Diagnostics, and Molecular Products segments. The Corporate and Diagnostics segment manufactures and distributes reagents and kits for bacterial and blood tests. The Molecular Products segment designs, manufactures, and distributes test kits for various diseases in humans, animals, and food products. The company's diagnostic products are used in oncology, microbiology, haematology, and serology testing. It also develops, manufactures, and distributes diagnostic products for food laboratories; and manufactures and supplies reagents and tests for in vitro diagnostic tests and blood grouping applications under the Plasmatec and Biotec brand names. The company has collaboration with AstraZeneca, GSK, and the University of Cambridge to support increase testing for COVID-19. It serves universities, hospitals, clinics, and testing laboratories. Novacyt S.A. was founded in 2006 and is headquartered in Camberley, the United Kingdom.

Frequently asked questions

More guides on Finder

  • How to buy Wilmington shares

    Ever wondered how to buy shares in Wilmington? We explain how and compare a range of providers that can give you access to many brands, including Wilmington.

  • How to buy Vertu Motors shares

    Ever wondered how to buy shares in Vertu Motors? We explain how and compare a range of providers that can give you access to many brands, including Vertu Motors.

  • How to buy Tribal Group shares

    Ever wondered how to buy shares in Tribal Group? We explain how and compare a range of providers that can give you access to many brands, including Tribal Group.

  • How to buy Time Out Group shares

    Ever wondered how to buy shares in Time Out Group? We explain how and compare a range of providers that can give you access to many brands, including Time Out Group.

  • How to buy SigmaRoc shares

    Ever wondered how to buy shares in SigmaRoc? We explain how and compare a range of providers that can give you access to many brands, including SigmaRoc.

  • How to buy Inspecs Group shares

    Ever wondered how to buy shares in Inspecs Group? We explain how and compare a range of providers that can give you access to many brands, including Inspecs Group.

  • How to buy Symphony International Holdings shares

    Ever wondered how to buy shares in Symphony International Holdings? We explain how and compare a range of providers that can give you access to many brands, including Symphony International Holdings.

  • How to buy Sigma Capital Group shares

    Ever wondered how to buy shares in Sigma Capital Group? We explain how and compare a range of providers that can give you access to many brands, including Sigma Capital Group.

  • How to buy Sensyne Health shares

    Ever wondered how to buy shares in Sensyne Health? We explain how and compare a range of providers that can give you access to many brands, including Sensyne Health.

  • How to buy Scancell Holdings shares

    Ever wondered how to buy shares in Scancell Holdings? We explain how and compare a range of providers that can give you access to many brands, including Scancell Holdings.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site